- Endava plc (NYSE:DAVA) reported a strong Q3 earnings per share (EPS) of $0.66, significantly beating analyst estimates, despite a revenue miss.
- Management attributed the revenue shortfall to client decision delays, extended sales cycles for large contracts, and geopolitical disruptions impacting profit margins.
- Despite these operational challenges, Endava maintains a robust financial position, evidenced by a healthy debt-to-equity ratio of 0.50 and a strong current ratio of 2.39.
Endava plc (NYSE:DAVA) is a technology company that helps businesses with their digital transformation. It focuses on areas like AI-native delivery and improving payment systems for its clients. The company recently reported its financial results for the third quarter of its fiscal year, providing insight into its current performance and challenges.
On May 21, 2026, Endava announced its quarterly earnings, reporting an earnings per share (EPS) of $0.66. This figure was significantly higher than the analyst consensus estimate of $0.27.
However, the company’s revenue for the quarter was approximately $236 million, which did not meet the analyst expectation of nearly $242.8 million. Management explained this shortfall was due to several factors. These include clients delaying decisions and longer sales cycles for large, outcome-based contracts, as highlighted by MarketBeat.
Chief Executive Officer John Cotterell described demand as “uneven” and noted the current climate is “one of the more challenging periods Endava has faced in recent years,” as reported by Business Wire. Geopolitical disruptions in the Middle East also caused clients to delay work. This led to lower-than-expected revenue, reduced profit margins, and a non-cash goodwill impairment.
Despite these difficulties, Endava maintains a solid financial position. The company has a debt-to-equity ratio of 0.50. Its current ratio of 2.39 suggests it has a strong ability to cover its short-term liabilities. This ratio compares a company’s current assets to its current liabilities, with a value above 1 generally seen as healthy.
